Theriva Biologics TOVX
NYSE TOVX
$0.24 +0.01 (+4.89%)
As of: Oct 2, 2026 · 3:56 PM EDT

Theriva Biologics (TOVX) Long-Term Debt Issuances (2025)

Updated

Theriva Biologics' Long-Term Debt Issuances came in at $15,000 for Q4 2025, down 55.9% from the prior quarter.

Analysis

Theriva Biologics (TOVX) Long-Term Debt Issuances (2025) Analysis & Trends

For FY2025, Theriva Biologics' Long-Term Debt Issuances was $1.51 million.

  • Business Quant data shows TOVX's Long-Term Debt Issuances at $34,000 (Q3 2025), $57,000 (Q2 2025) and $1.4 million (Q1 2025) in the three quarters before Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 1.98 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Theriva Biologics 10.56 Mn 10.56 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 15,000.00
Sep 30, 2025 34,000.00
Jun 30, 2025 57,000.00
Mar 31, 2025 1.40 Mn
API Access

Theriva Biologics Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=TOVX&period=max&api_key=YOUR_API_KEY